ID Epi Seminar Series: The incidence, etiology, and clinical sequelae of diarrheal diseases in African children before and after rotavirus vaccine introduction, Karen Kotloff, MD, Univ. of Maryland

Kresge G2, Harvard Chan School 677 Huntington Ave., Boston, MA

Karen Kotloff, MD, Professor of Pediatrics; Head of the Division of Infectious Disease and Tropical Pediatrics; Associate Director of Clinical Studies at the Center for Vaccine Development, University of Maryland School of Medicine Talk Title: The incidence, etiology, and clinical sequelae of diarrheal diseases in African children before and after rotavirus vaccine introduction Biography:  Dr. Kotloff is Head of Pediatric Infectious Disease at the University of Maryland School of Medicine…

ID Epi Seminar Series: Katia Koelle

Kresge Building, Room 502, Harvard Chan School 677 Huntington Ave., Boston, MA

Bio: Katia Koelle is an Associate Professor in the Department of Biology at Emory University. She earned her PhD in Ecology and Evolutionary Biology from the University of Michigan (2005) and recently joined the Department of Biology at Emory after a decade on the faculty at Duke University. Her research interests include the development of mathematical models to better understand patterns of viral evolution and disease dynamics between and within…

ID Epi Seminar Series: Jacob Bor

Kresge G2, Harvard Chan School 677 Huntington Ave., Boston, MA

Jacob Bor, ScD, SM, is Assistant Professor and Peter T. Paul Career Development Professor in the Departments of Global Health and Epidemiology at Boston University School of Public Health. His research applies the analytical tools of economics and data science to the study of population health, with focus areas on HIV treatment and prevention in southern Africa and on U.S. health disparities. Current research interests include the economics of health behaviors;…

ID Epi Seminar Series: Kathleen Neuzil

Kresge Building, Room 502, Harvard Chan School 677 Huntington Ave., Boston, MA

Bio: Dr. Neuzil is a Professor of Medicine and Pediatrics, Director of the Center for Vaccine Development and Global Health (CVD), and Director of the Division of Geographic Medicine at the University of Maryland School of Medicine. She received her BS in zoology from the University of Maryland, College Park, her MD from Johns Hopkins University School of Medicine, and her MPH from Vanderbilt University. She received her training in…

ID Epi Seminar Series: Duncan MacCannell

Kresge Building, Room 502, Harvard Chan School 677 Huntington Ave., Boston, MA

  Duncan MacCannell is the chief science officer for the CDC’s Office of Advanced Molecular Detection (OAMD), where he helps to coordinate the implementation and support of pathogen genomics, bioinformatics, high-performance computing and other innovative laboratory technologies across the CDC’s four infectious disease centers. With a broad focus on public health laboratory science and strategic innovation, he directs the agency's high performance computing center of excellence, and works to integrate…

ID Epi Seminar Series: Robert Woods

Kresge Building, Room 502, Harvard Chan School 677 Huntington Ave., Boston, MA

Dr Robert Woods is an infectious diseases physician-scientist. The common theme of his research is the study of ecological and evolutionary forces that maintain diversity in pathogen populations by combining theory, bioinformatics, laboratory experiments and clinical data, with the goal to better understand pathogen evolution, predict medically relevant evolutionary phenomena and rationally designing interventions. In his Ph.D. Dr. Woods used experimental evolution with E. coli and computer simulations to understand…

ID Epi Seminar Series: Natalie Dean

Kresge Building, Room 502, Harvard Chan School 677 Huntington Ave., Boston, MA

Natalie Dean is an Assistant Professor in the Department of Biostatistics at the University of Florida. Her research is on methods for clinical trial and study design for evaluating vaccine efficacy, with a focus on emerging infectious diseases such as Ebola, Zika, and Lassa fever. She is Principal Investigator of an NIH/NIAID R01 to develop and evaluate innovative trial design and analysis methods adapted to the outbreak setting. She received…